2796 — Pharmarise Holdings Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.88 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 2.28 | ||
| Price to Sales | 0.08 | ||
| EV to EBITDA | 6.73 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.82% | ||
| Return on Equity | 1.45% | ||
| Operating Margin | 1.23% | ||
Financial Summary
| Year End 31st May | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 51,608 | 52,030 | 54,466 | 63,508 | 69,512 | n/a | n/a | 5.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -5.76 | -6.12 | -35.17 | -34.77 | +93.74 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pharmarise Holdings Corporation is primarily engaged in the dispensing pharmacy business. The Company operates through four business segments. The Dispensing Pharmacy segment involves operating pharmacies that dispense prescription medicines to patients based on prescriptions issued by medical institutions, functioning as insurance pharmacies under the Health Insurance Act. The Retail Sales segment involves selling non-prescription items such as over-the-counter (OTC) drugs, sanitary supplies, cosmetics, and daily necessities through outlets such as drugstores and convenience stores. The Medical Records Storage and Management segment involves storing and managing medical records such as patient charts created during medical examinations in warehouses on behalf of medical institutions. The Medical Mall Management segment involves the operation of a medical mall located within the JR Tower Office Plaza Sapporo at JR Sapporo Station.
Directors
- Toshimichi Ohno CHM (68)
- Masayuki Akiyama PRE (51)
- Keiko Matsuura SMD (61)
- Sayoko Ohno MDR (67)
- Masahito Akamatsu EXO (60)
- Yutaka Numata EXO (55)
- Mitsugu Takahashi EXO (56)
- Hiroshi Kanno EXO (44)
- Motohiro Kimijima EXO
- Masanori Maruta EXO
- Katsuya Nunome EXO
- Minoru Sato EXO
- Nobuo Taguchi EXO
- Yoshihiro Tanaka EXO
- Hiroshi Terakawa EXO
- Tetsuo Onaka IND (85)
- Hiroshi Tada IND (81)
- Norio Watanabe IND
- Last Annual
- May 31st, 2026
- Last Interim
- August 31st, 2026
- Incorporated
- June 28th, 1984
- Public Since
- February 1st, 2007
- No. of Shareholders
- 20,109
- No. of Employees
- 2,031
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 11,511,375
- Address
- 1-38-1, Chuo, NAKANO-KU, 164-0011
- Web
- https://www.pharmarise.com/
- Phone
- +81 333627130
- Auditors
- Grant Thornton Taiyo LLC
Latest News for 2796
Upcoming Events for 2796
Dividend For 2796.T - 0.0000 JPY
Q2 2027 Pharmarise Holdings Corp Earnings Release
Q3 2027 Pharmarise Holdings Corp Earnings Release
Similar to 2796
AEON
Tokyo Stock Exchange
Ain Holdings
Tokyo Stock Exchange
Albis
Tokyo Stock Exchange
ALPICO HOLDINGS
Tokyo Stock Exchange
Arcs
Tokyo Stock Exchange
FAQ
As of Today at 04:42 UTC, shares in Pharmarise Holdings are trading at ¥506. This share price information is delayed by 15 minutes.
Shares in Pharmarise Holdings last closed at ¥506 and the price had moved by -5.77% over the past 365 days. In terms of relative price strength the Pharmarise Holdings share price has underperformed the Nikkei 225 Index by -26.89% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Pharmarise Holdings dividend yield is 2.77% based on the trailing twelve month period.
Last year, Pharmarise Holdings paid a total dividend of ¥14, and it currently has a trailing dividend yield of 2.77%. We do not have any data on when Pharmarise Holdings is to next pay dividends.
We do not have data on when Pharmarise Holdings is to next pay dividends. The historic dividend yield on Pharmarise Holdings shares is currently 2.77%.
To buy shares in Pharmarise Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥506, shares in Pharmarise Holdings had a market capitalisation of ¥6bn.
Here are the trading details for Pharmarise Holdings:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 2796
Based on an overall assessment of its quality, value and momentum Pharmarise Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharmarise Holdings. Over the past six months, its share price has underperformed the Nikkei 225 Index by -6.76%.
As of the last closing price of ¥506, shares in Pharmarise Holdings were trading -0.62% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Pharmarise Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥506.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Pharmarise Holdings' management team is headed by:
- Toshimichi Ohno - CHM
- Masayuki Akiyama - PRE
- Keiko Matsuura - SMD
- Sayoko Ohno - MDR
- Masahito Akamatsu - EXO
- Yutaka Numata - EXO
- Mitsugu Takahashi - EXO
- Hiroshi Kanno - EXO
- Motohiro Kimijima - EXO
- Masanori Maruta - EXO
- Katsuya Nunome - EXO
- Minoru Sato - EXO
- Nobuo Taguchi - EXO
- Yoshihiro Tanaka - EXO
- Hiroshi Terakawa - EXO
- Tetsuo Onaka - IND
- Hiroshi Tada - IND
- Norio Watanabe - IND